Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bipolar disorder.

Bruno Müller-Oerlinghausen1, Anne Berghöfer, Michael Bauer

  • 1Department of Psychiatry, Research Group of Clinical Psychopharmacology, Freie Universität Berlin, Berlin, Germany.bmoe@zedat.fu-berlin.de

Lancet (London, England)
|January 29, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Digital crisis counseling during wartime: Pre-post outcomes and user experience in Ukrainian and German samples.

Internet interventions·2026
Same author

Efficacy of parent-infant psychotherapy with mothers with postpartum mental disorder: results from a randomized controlled trial.

Child and adolescent psychiatry and mental health·2026
Same author

Cost-effectiveness of short-term parent-infant-psychotherapy, results from two randomized controlled trials.

Cost effectiveness and resource allocation : C/E·2025
Same author

Reduced Trust in Bodily Sensations Predicts Suicidal Ideation in Hospitalized Patients With Major Depression: An Observational Study.

Suicide & life-threatening behavior·2025
Same author

Effect of osteopathic manipulative treatment on comorbid depressive symptoms in patients with chronic low back pain: study protocol for a randomised controlled trial.

BMJ open·2025
Same author

Psychiatric disorders in psychosocially burdened mothers with young children: a population-based cohort study in Germany.

Frontiers in psychiatry·2025
Same journal

Convergence of metabolic risk in obesity and normal BMI: does risk disappear?

Lancet (London, England)·2026
Same journal

Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

Lancet (London, England)·2026
Same journal

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Lancet (London, England)·2026
Same journal

The US Ebola response and the future of global health leadership.

Lancet (London, England)·2026
Same journal

Daniel Mason: a tale of change.

Lancet (London, England)·2026
Same journal

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

Lancet (London, England)·2026
See all related articles

Bipolar disorder, a severe mood disorder, has high morbidity and suicide rates. Lithium salts are the primary long-term treatment for bipolar disorder, offering proven antisuicidal effects.

Area of Science:

  • Psychiatry
  • Neuroscience
  • Mood Disorders

Background:

  • Bipolar disorder (manic-depressive illness) is a common, severe, recurrent mood disorder with significant morbidity.
  • Lifetime prevalence is 1.3-1.6%, with mortality rates 2-3 times higher than the general population.
  • Suicide risk is substantial, with 10-20% of patients dying by suicide and nearly a third attempting it.

Purpose of the Study:

  • To review the characteristics and treatment of bipolar disorder.
  • To highlight the importance of long-term prophylactic treatment.
  • To discuss the efficacy of different pharmacological interventions.

Main Methods:

  • Review of existing literature on bipolar disorder.
  • Analysis of prevalence, morbidity, and mortality data.

Related Experiment Videos

  • Evaluation of pharmacological treatment options, including lithium, carbamazepine, and valproate.

    • Main Results:

    • Bipolar disorder presents with diverse clinical manifestations, from hypomania to severe psychosis.
    • Long-term prophylactic pharmacological treatment is essential due to high recurrence and suicide risks.
    • Lithium salts are the first-line treatment, demonstrating significant antisuicidal effects.
    • Carbamazepine and valproate are second-choice options with less robust evidence.

    Conclusions:

    • Bipolar disorder requires long-term management to mitigate recurrence and suicide risk.
    • Lithium remains the gold standard for prophylactic treatment in bipolar disorder.
    • Further research may be needed to strengthen evidence for second-line treatments.